Advanced search×

Current Diabetes Reports

Print ISSN
Electronic ISSN
Impact factor
Usage rank
Article count
Free count
Free percentage
PDFs via platforms
Metapress, Gale, and Springer

  1. Glycemic targets in pregnancies affected by diabetes: historical perspective and future directions.

    Current Diabetes Reports 15(1):565 (2015) PMID 25398204

    The definition of optimal glycemic control in pregnancies affected by diabetes remains enigmatic. Diabetes phenotypes are heterogeneous. Moreover, fetal macrosomia insidiously occurs even with excellent glycemic control. Current blood glucose (BG) targets (FBG ≤95, 1-h post-prandial <120 m...
  2. Ultra widefield fundus imaging for diabetic retinopathy.

    Current Diabetes Reports 14(8):514 (2014) PMID 24935049

    For decades, the standard method for screening and grading severity of diabetic retinal disease has relied upon a montage of photographs using normal angle fundus cameras. With the development of ultrawide field (UWF) fundus imaging, more of the retina can be imaged with fewer pictures, less depende...
  3. Environmental endocrine disruption of energy metabolism and cardiovascular risk.

    Current Diabetes Reports 14(6):494 (2014) PMID 24756343 PMCID PMC4067479

    Rates of metabolic diseases have increased at an astounding rate in recent decades. Even though poor diet and physical inactivity are central drivers, these lifestyle changes alone fail to fully account for the magnitude and rapidity of the epidemic. Thus, attention has turned to identifying novel r...
  4. The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery.

    Current Diabetes Reports 14(5):481 (2014) PMID 24705810 PMCID PMC4059201

    We discuss the various types of surgical interventions and the multitude of factors that potentially mediate the effects on glycemia, such as altered delivery of nutrients to the distal ileum, duodenal exclusion, gut hormone changes, bile acid reabsorption, and amino acid metabolism. Accumulating ev...
  5. Risk vs benefit in diabetes pharmacotherapy: a rational approach to choosing pharmacotherapy in type 2 diabetes.

    Current Diabetes Reports 13(3):319 (2013) PMID 23512666

    We review the commonly prescribed pharmacotherapy options with attention to recently published information and provide a rational approach to choice of therapy....
  6. Novel targets against retinal angiogenesis in diabetic retinopathy.

    Current Diabetes Reports 12(4):355 (2012) PMID 22638940

    Proliferative diabetic retinopathy (PDR), characterized by pathologic retinal angiogenesis, is a major cause of blindness in the USA and globally. Treatments targeting vascular endothelial growth factor (VEGF) have emerged as a beneficial part of the therapeutic armamentarium for this condition, hig...
  7. Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease.

    Current Diabetes Reports 10(4):297 (2010) PMID 20532701 PMCID PMC3044643

    Blockade of the renin-angiotensin-aldosterone system (RAAS) prevents the development and progression of diabetic kidney disease (DKD). It is controversial whether the simultaneous use of two RAAS inhibitors (ie, dual RAAS blockade) further improves renal outcomes. This review examines the scientific...
  8. Current concepts about chromium supplementation in type 2 diabetes and insulin resistance.

    Current Diabetes Reports 10(2):145 (2010) PMID 20425574

  9. Best strategies for hypertension management in type 2 diabetes and obesity.

    Current Diabetes Reports 10(2):139 (2010) PMID 20425573

  10. The Eurodiab study: what has this taught us about diabetic peripheral neuropathy?

    Current Diabetes Reports 9(6):432 (2009) PMID 19954687

    Apart from tight blood glucose control, no other treatments have been shown to retard the progression of diabetic peripheral neuropathy (DPN). Therefore, identifying potential risk factors for DPN is important, particularly if they are modifiable. The Eurodiab baseline DPN study found a prevalence o...